IPTG Clinical Trials

Size	Price	Qty
100mg	USD 147
1g	USD 197

Clinical Trials

A clinical trial sponsored by an academic institution, the Tulane University School of Social Work, has completed recruitment without an assigned clinical phase to evaluate the intervention program. The study targeted observational and behavioral conditions, focusing on adolescent behavior, risk reduction, and psychological stress to mitigate health risks and support emotional well-being. Overall, this research underscores an emphasis on behavioral health interventions rather than traditional therapeutic drug development.

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
NCT02386878	COMPLETED	Adolescent Behavior; Risk Reduction Behavior; Stress, Psychological	Tulane University School of Social Work	2012-01

(data from https://clinicaltrials.gov, updated on 2017-03-13)

Check the IPTG product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.

Compliance for Clinical Use

Mechanism and Biochemical Profile

Isopropyl β-D-thiogalactoside functions as a non-metabolizable molecular mimic of allolactose that binds directly to the lac repressor protein, inducing a conformational change that prevents operator binding and derepresses gene transcription to stimulate protein expression. While this biochemical mechanism primarily drives recombinant protein synthesis in laboratory settings, clinical evaluations linked to this entry focus on behavioral interventions targeting adolescent behavior, risk reduction behavior, and psychological stress.

Appendix RUO and cGMP Quality Standards

Quality Dimension	RUO (Research Use Only)	cGMP (Current Good Manufacturing Practice)
Clinical Applicability	Prohibited in human clinical trials or medical diagnostics.	Mandatory for human clinical trials (Phase I–III) and therapies.
Regulatory Status	Non-regulated grade; exempt from drug manufacturing laws.	Legally enforced by health authorities (e.g., FDA, EMA, NMPA).
Facility Environment	Unclassified analytical or research laboratories.	Validated Cleanrooms (ISO Class 5–8) with continuous monitoring.
Quality Control	Basic purity and activity testing.	Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma).
Process Validation	Basic equipment calibration; no process validation required.	Full qualification (IQ/OQ/PQ) and complete batch records.
Quality Assurance	Vendor self-declared without required formal QMS.	Mandatory QA/QC unit, Change Control, CAPA, and vendor audits.
Regulatory Impact	High risk of IND rejection if used as a critical raw material.	Required for IND/NDA filings, supported by Drug Master Files (DMF).

Footnotes

Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).